Issue link: https://www.e-digitaleditions.com/i/1527415
Inhalation OctOber 2024 19 Simulating breathing patterns for inhaler testing Breathing simulators (BRS) are essential tools in the pharmaceutical industry, particularly for testing inhalers. ese devices replicate human breathing patterns, allowing for accurate assessment of inhaler performance under various conditions. By simulating different respiratory rates and volumes, BRS ensure that inhalers deliver the correct dosage of medication to the lungs. is testing is crucial for verifying the efficacy and safety of inhaler devices before they reach the market. Overall, BRS is used in the development of reliable and effective respiratory treatments. MSP™, a Division of TSI ® US: +1 651 287-8100 mspsales@tsi.com www.tsi.com Dry powder inhalers Merxin Ltd: we are experts in dry powder inhal- ers (DPIs). We design and supply two DPIs. Our MRX003 capsule DPI is currently on sale in the EU and is a high resistance device. High resistance cap- sule DPIs are the most prescribed capsule inhalers in the world. Our MRX006 multidose DPI is a blister DPI based on the easy to use open-inhale-close prin- ciple. Its blister has two cavities to increase the dose delivered or accommodate two independently formu- lated APIs. Contact Merxin today to see how we can launch your next formulation. We Make Inhalers. We Will Launch You. Make It Better. Merxin, Ltd. UK: +44 1553 403070 info@merxin.com www.merxin.com Respiratory drug product development software Fusion Process Development (FPD) for respiratory drug product R&D is the perfect companion mod- ule to Fusion Inhaler Testing (FIT) for QC. FPD has automated Design of Experiments (DoE) and data modeling for formulation and process R&D. FPD enables you to create companion testing designs for your formulation and device design studies with full bi-directional Chromatography Data Software (CDS) testing automation. Automated CDS testing and data retrieval includes handling of complex data from cas- cade impaction testing and dissolution testing. And FPD operates under full regulatory compliance to maintain data integrity. S-Matrix ® US: +1 707 441-0406 sales@smatrix.com www.smatrix.com MDI canister coating Big changes are coming, especially related to future per- and polyfluoroalkyl substances (PFAS) bans. Biomerics can help you stay out in front of them with our new, patent pending, 100% PFAS-free metered dose inhaler (MDI) canister coating. So far, pharma- ceutical test results show equivalency to current PFAS coatings. Please reach out to us and let us know how we can support your MDI projects. Biomerics US: +1 540 246-1930 rchurchill@biomerics.com www.biomerics.com